Local feedback mechanisms in human breast cancer

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2000-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/A:1006430202101PMID 11097086
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: Anin situ hybridization and immunohistochemistry study

  2005cited by this paper
• The multifunctional role of transforming growth factor (TGF)-ßs on mammary epithelial cell biology

  2005cited by this paper
• Prolactin and Mammary Gland Development

  2004influential reference
• Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.

  1999cited by this paper
• Spatial and temporal expression of insulin-like growth factor-I, insulin-like growth factor-II and the insulin-like growth factor-I receptor in the sheep fetal mammary gland

  1999cited by this paper
• Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts.

  1999cited by this paper
• Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD.

  1999cited by this paper
• Transforming growth factor-beta 1 increases the adhesion of MDA-MB-231 mammary adenocarcinoma cells to the microvascular subendothelium.

  1999cited by this paper
• Inhibitors of protein kinases: CGP 41251, a protein kinase inhibitor with potential as an anticancer agent.

  1999cited by this paper
• Tumor Dormancy Induced by Downregulation of Urokinase Receptor in Human Carcinoma Involves Integrin and MAPK Signaling

  1999cited by this paper
• Interleukin-1 receptor-ligand interactions modulate interstitial collagenase-1 production by human endometrial fibroblasts.

  1999cited by this paper
• TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.

  1999cited by this paper
• A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.

  1999cited by this paper
• Recent advances in bone biology provide insight into the pathogenesis of bone diseases.

  1999cited by this paper
• Relationships between vascularization and proliferation in invasive breast cancer

  1999cited by this paper
• Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development.

  1999cited by this paper
• Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.

  1998cited by this paper
• Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.

  1998cited by this paper
• Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors

  1998cited by this paper
• Estrogen-induced keratinocyte growth factor mRNA expression in normal and cancerous human breast cells.

  1998cited by this paper
• Cellular expression of growth hormone and prolactin receptors in human breast disorders

  1998cited by this paper
• Expression of growth factors, growth‐inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis

  1998cited by this paper
• Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops

  1998cited by this paper
• Local control of mammary development and function.

  1998cited by this paper
• Ontogeny and epithelial-stromal interactions regulate IGF expression in the ovine mammary gland.

  1998cited by this paper
• NF-kappaB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha.

  1998cited by this paper
• NF-κB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1α

  1998cited by this paper
• Induction of Hepatocyte Growth Factor in Fibroblasts by Tumor-derived Factors Affects Invasive Growth of Tumor Cells : In Vitro Analysis of Tumor-Stromal Interactions

  1998cited by this paper
• Expression of Transforming Growth Factor β (TGFβ) Type III Receptor Restores Autocrine TGFβ1 Activity in Human Breast Cancer MCF-7 Cells*

  1997cited by this paper
• Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture.

  1997cited by this paper
• Transforming growth factor-β in breast cancer: A working hypothesis

  1997cited by this paper
• Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.

  1997cited by this paper
• Expression of transforming growth factor beta (TGFbeta) type III receptor restores autocrine TGFbeta1 activity in human breast cancer MCF-7 cells.

  1997cited by this paper
• Aromatase expression and its localization in human breast cancer.

  1997cited by this paper
• Transforming growth factor-beta in breast cancer: a working hypothesis.

  1997cited by this paper
• Parathyroid hormone‐related protein and bone metastases

  1997cited by this paper
• Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions.

  1997cited by this paper
• Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder.

  1997cited by this paper
• Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells.

  1997cited by this paper
• Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site.

  1997cited by this paper
• Insulin-like growth factor binding proteins and their role in controlling IGF actions.

  1997cited by this paper
• Vascular expression of E-selectin is increased in estrogen-receptor-negative breast cancer: a role for tumor-cell-secreted interleukin-1 alpha.

  1997cited by this paper
• Alteration of integrins by heparin-binding EGF-like growth factor in human breast cancer cells.

  1996cited by this paper
• HGF receptor associates with the anti‐apoptotic protein BAG‐1 and prevents cell death.

  1996cited by this paper
• Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells.

  1996cited by this paper
• Modulatory action of epidermal growth factor on differentiated human granulosa lutein cells: cross-talk between ligand activated receptors for EGF and gonadotropin.

  1996cited by this paper
• Host response in tumor growth and progression.

  1996cited by this paper
• Biologic basis for interleukin-1 in disease.

  1996cited by this paper
• Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.

  1996cited by this paper
• Expression of the gene encoding growth hormone in the human mammary gland.

  1995cited by this paper
• Tumor-stroma interactions and stromal cell density regulate hepatocyte growth factor protein levels: a role for transforming growth factor-beta activation.

  1995cited by this paper
• Aromatase activity and interleukin-6 production by normal and malignant breast tissues.

  1995cited by this paper
• Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women.

  1995cited by this paper
• Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid.

  1995influential reference
• Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis.

  1995influential reference
• Coexpression of TGF alpha, epidermal growth factor receptor, and P-glycoprotein in normal and benign diseased breast tissues.

  1995cited by this paper
• Cytokine signal transduction.

  1995cited by this paper
• Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop.

  1995cited by this paper
• Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function.

  1995cited by this paper
• Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators.

  1995cited by this paper
• Ovulation induction and endometrial steroid receptors.

  1994cited by this paper
• Tumor metastasis to brain: role of endothelial cells, neurotrophins, and paracrine growth factors.

  1994cited by this paper
• Cytokine signal transduction.

  1994cited by this paper
• Involvement of neurotrophins and growth factors in brain metastasis formation.

  1994cited by this paper
• Role of Hepatocyte Growth Factor in Breast Cancer: A Novel Mitogenic Factor Secreted by Adipocytes

  1994cited by this paper
• Stromal spindle cells contain aromatase in human breast tumors.

  1994cited by this paper
• Identification of the aromatase in the breast carcinoma cell lines T47D and MCF-7.

  1994cited by this paper
• Extracellular matrix regulates expression of the TGF-beta 1 gene

  1993cited by this paper
• Transcription of prolactin gene in milk secretory cells of the rat mammary gland.

  1993cited by this paper
• Extracellular Matrix Regulates Expression of the Tgf-/31 Gene

  1993influential reference
• Control of aromatase in breast cancer cells and its importance for tumor growth.

  1993cited by this paper
• Evidence that the growth hormone receptor mediates differentiation and development of the mammary gland.

  1993cited by this paper
• Role of growth hormone and insulin-like growth factor-I in mammary development.

  1993cited by this paper
• Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1

  1992cited by this paper
• Steroid and growth factor modulation of aromatase activity in MCF7 and T47D breast carcinoma cell lines.

  1992cited by this paper
• Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression.

  1992cited by this paper
• Determination of aromatase cytochrome P450 messenger ribonucleic acid in human breast tissue by competitive polymerase chain reaction amplification.

  1992cited by this paper
• Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions.

  1991cited by this paper
• Human Reproductive Biology

  1991cited by this paper
• Mechanisms of osteolytic bone destruction.

  1991cited by this paper
• Transforming Growth Factor-β Induces Platelet-Derived Growth Factor (PDGF) Messenger RNA and PDGF Secretion while Inhibiting Growth in Normal Human Mammary Epithelial Cells

  1990cited by this paper
• Transforming growth factor-beta induces platelet-derived growth factor (PDGF) messenger RNA and PDGF secretion while inhibiting growth in normal human mammary epithelial cells.

  1990cited by this paper
• Expression of the transforming growth factor-alpha/epidermal growth factor receptor pathway in normal human breast epithelial cells.

  1990cited by this paper
• Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations.

  1989cited by this paper
• Aromatase activity in adipose tissue from breast quadrants: A link with tumor site

  1989cited by this paper
• in situ oestrone synthesis in normal breast and breast tumour tissues: Effect of treatment with 4‐hydroxyandrostenedione

  1989cited by this paper
• Aromatase activity in adipose tissue from breast quadrants: a link with tumour site

  1988cited by this paper
• Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines.

  1987cited by this paper
• DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture.

  1986cited by this paper
• A dual effector theory of growth-hormone action.

  1985cited by this paper
• Feedback effects of mammary gland tumors on the host pituitary prolactin cell.

  1981cited by this paper
• Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells.

  1980cited by this paper
• Printed in U.S.A. Copyright © 1998 by The Endocrine Society Evidence That the Mammary Fat Pad Mediates the Action of Growth Hormone in Mammary Gland Development

  year unknowncited by this paper

• Adaptive biohybrid pumping machine with flow loop feedback

  2022cites this paper
• Inflammatory Amplification: A Central Tenet of Uterine Transition for Labor

  2021cites this paper
• Chemokines: key players in cancer progression and metastasis.

  2011cites this paper
• Chemokines and chemokine receptors in cancer progression

  2009cites this paper
• What can we learn from rodents about prolactin in humans?

  2008cites this paper
• Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations.

  2007cites this paper
• Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.

  2006cites this paper
• Clinicopathological Significance of Stromal Myofibroblasts in Invasive Ductal Carcinoma of the Breast

  2004cites this paper
• Pharmacological modulation of IGF serum concentrations as a therapeutic approach to control the growth of malignant breast tumors.

  2003cites this paper